{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Treace Medical Concepts, Inc.
Is Treace Medical Concepts, Inc. technically bullish or bearish?
As of September 2, 2025, Treace Medical Concepts, Inc. shows a mildly bearish trend with mixed indicators, underperforming the S&P 500 year-to-date at -3.36% but outperforming it over the past year with a return of 31.2%.
Is Treace Medical Concepts, Inc. technically bullish or bearish?
As of May 28, 2025, the technical trend is bearish with moderate strength, indicated by bearish MACD, moving averages, and KST, while Bollinger Bands also suggest a continuation of this trend without immediate reversal signals.
What does Treace Medical Concepts, Inc. do?
Treace Medical Concepts, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $53 million and a net loss of $16 million as of March 2025. The company has a market cap of $342.20 million and does not pay dividends.
How big is Treace Medical Concepts, Inc.?
As of Jun 18, Treace Medical Concepts, Inc. has a market capitalization of 342.20 million and reported net sales of 210.82 million with a net profit of -52.99 million over the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
